Follistim (follitropin beta) contains human follicle stimulating hormone (FSH) that is manufactured using recombinant DNA technology. Follistim AQ 75 IU and 150 IU vials are packaged in 0.5cc premixed aqueous vials for subcutaneous or intramuscular administration. It is indicated for the development of multiple follicles in ovulatory patients participating in an assisted reproductive technology (ART) program. It is also indicated for the induction of ovulation and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure.
< Back 
